Virtu Financial’s VanEck Biotech ETF BBH Stock Holding History

Virtu Financial’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-22,818	Closed	-$2.69M	–	1436
2019 Q3	$2.69M	Buy	+22,818	New	+$2.84M	0.21%	78
2019 Q2	–	Sell	-21,392	Closed	-$2.75M	–	1460
2019 Q1	$2.75M	Sell	21,392 -12,097	-36%	-$1.53M	0.16%	82
2018 Q4	$3.72M	Buy	33,489 +5,892	+21%	+$712K	0.2%	61
2018 Q3	$3.76M	Buy	+27,597	New	+$3.59M	0.23%	72
2018 Q2	–	Sell	-11,393	Closed	-$1.37M	–	1978
2018 Q1	$1.37M	Buy	11,393 +647	+6%	+$81.2K	0.07%	255
2017 Q4	$1.34M	Buy	+10,746	New	+$1.37M	0.07%	328
2017 Q2	–	Sell	-50,916	Closed	-$6.06M	–	387
2017 Q1	$6.06M	Buy	+50,916	New	+$5.95M	0.63%	23
2016 Q3	–	Sell	-32,958	Closed	-$3.38M	–	367
2016 Q2	$3.38M	Buy	32,958 +5,982	+22%	+$638K	0.45%	40
2016 Q1	$2.8M	Buy	+26,976	New	+$2.81M	0.39%	67
2015 Q2	–	Sell	-122,112	Closed	-$15.8M	–	309
2015 Q1	$15.8M	Buy	+122,112	New	+$15.3M	1.74%	14

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Virtu Financial's BBH Position: Q4 2019 in Review

Virtu Financial sold out of VanEck Biotech ETF (BBH) in Q4 2019, closing a stake of 22,818 shares — an estimated $2.69M sold.

Virtu Financial first reported a position in BBH in Q1 2015 and held it in 10 quarters. The position peaked at $15.8M in Q1 2015. 87 funds tracked by Wall St. Rank hold BBH as of Q4 2019.

Virtu Financial reported no remaining VanEck Biotech ETF position as of Q4 2019 after selling out during the quarter.
Virtu Financial sold 22,818 VanEck Biotech ETF shares in Q4 2019, an estimated $2.69M.
Virtu Financial first reported a position in VanEck Biotech ETF in Q1 2015 and held it in 10 quarters.
Virtu Financial's VanEck Biotech ETF position peaked at $15.8M in Q1 2015.
87 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.